Application of Smart Nanosystems in Targeted Drug Delivery for Cancer Therapy: From Design to Clinical Trials

Application of Smart Nanosystems in Targeted Drug Delivery for Cancer Therapy: From Design to Clinical Trials

Fatemah Nazari1 Yasin SarveAhrabi2

1) Department of Microbiology, TeMS.C., Islamic Azad University, Tehran, Iran. E-mail:
2) Department of Biology, CT.C., Islamic Azad University, Tehran, Iran. E-mail:

IOI Code : AADG-ABABKF
Publication : The second international conference on new approaches in engineering and basic sciences(icnabs.ir/2nd)
Abstract :
    The advent of nanotechnology has revolutionized cancer therapy by enabling the development of smart nanosystems for targeted drug delivery. These engineered constructs, typically ranging from 10 to 200 nm, are designed to improve the therapeutic index of anticancer agents by enhancing tumor-specific accumulation while minimizing systemic toxicity. This review provides a comprehensive analysis of the journey of smart nanosystems from fundamental design principles to clinical application. We discuss the core design pillars, including material selection, surface engineering for stealth and active targeting, and the incorporation of stimuli-responsive elements for controlled drug release. The mechanisms of passive targeting via the Enhanced Permeability and Retention (EPR) effect and active targeting through ligand-receptor interactions are critically examined. Furthermore, we delve into the biological barriers faced by nanosystems, from systemic circulation and tumor penetration to cellular uptake and intracellular trafficking. The review synthesizes preclinical evidence supporting the efficacy of various platforms, including polymeric nanoparticles, liposomes, and inorganic nanosystems, and highlights key candidates that have transitioned into clinical trials. Finally, we address the pivotal translational challenges related to manufacturing reproducibility, long-term safety, immunogenicity, and regulatory pathways. By integrating insights from materials science, molecular biology, and clinical oncology, this article outlines the current landscape and future directions for realizing the full potential of smart nanomedicines in personalized cancer therapy.

Keywords : smart nanosystems targeted drug delivery cancer therapy epr effect stimuli responsive nanomedicine translation